Navigation Links
Hope For Patients With Lung Cancer

Results from a new study offer a ray of hope for patients with non-small cell lung cancer.Researchers from around the world are // involved in research on the drug Tarceva, trying to determine its effect on different cancers -- including lung cancer.

Tarceva is a small molecule designed to target the human epidermal growth factor receptor (HER1) pathway, also known as EGFR, which is critical to cell growth in many cancers. This study included 731 patients with stage III or stage IV non-small cell lung cancer who had their cancer progress even after chemotherapy.

Researchers found Tarceva (erlotinib) improves survival of advanced non-small lung cancer patients by 40 percent. These are patients who did not respond to standard therapy. Researchers say, until now, no treatments have been effective for these individuals. Researchers also found that those on Tarceva survived an average of 6.7 months compared to 4.7 months for those on standard therapy. Although, it’s a difference of only two months, researchers say it’s a significant finding. That’s also an average -- meaning some patients live beyond those additional two months.

Researchers say the quality of life among patients in the Tarceva group was better than those on standard therapy. Rash and diarrhea were the most commonly reported side effects.
'"/>




Page: 1

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patients often assume wrongly that they are allergic to penicillin
7. New FDA Approved Drug NATRECOR For Heart Failure Patients
8. Hemochromatosis Patients Blood is Safe
9. Patients Pressure Would Result In Overprescription
10. Risk Of Decongestants In Hypertensive Patients
11. Interference helps Heart Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/17/2019)... ... ... A clinical article reviewing the long-term performance of the latest structured breast ... - The Meeting 2019 in San Diego last month. The article, titled “IDEAL IMPLANT ... Nichter, M.D., Robert A. Hardesty, M.D., and Gregg M. Anigian, M.D., and was published ...
(Date:10/15/2019)... FALLS CHURCH, Va. (PRWEB) , ... October 15, ... ... Combination Products:, Complying with FDA’s Most Recent IFU Guidance , **An FDAnews Webinar**, ... does the recent Instructions for Use (IFU) guidance have on new drug applications ...
(Date:10/11/2019)... ... 2019 , ... Only 6% of orthopedic surgeons in the country are women ... female physician leading the sports medicine program. These four work with a whole host ... traditionally male-oriented fields. , Orthopedic medicine deals with the correction of differences ...
(Date:10/10/2019)... ... October 10, 2019 , ... Santa Rosa ... services for the healthcare industry, has completed the first phase of a comprehensive ... Commonwealth of The Bahamas towards a fully integrated health information management system (iHIMS). ...
(Date:10/8/2019)... British Columbia (PRWEB) , ... October 08, 2019 , ... ... the current and future state of aging and wellness in the nation? That question ... Council on Active Aging Conference, Leadership Summit and Expo. The event will take place ...
Breaking Medicine News(10 mins):
(Date:10/19/2019)... ... ... A popular performer and iconic figure in the world of acting, Laurence Fishburne also ... the goal of educating its viewing audience on some of the many issues that ... the world of healthcare. One of the new episodes of "Behind the Scenes" takes ...
(Date:10/17/2019)... ... October 17, 2019 , ... Mount Sinai researchers have identified ... who would otherwise have no treatment options, according to a study published in ... and aggressive pediatric nervous system tumors and generally has a poor prognosis, particularly ...
(Date:10/17/2019)... ... October 17, 2019 , ... Women’s concern in the ... brand of textured implants is the subject of a September 24 article ... J says that the Allergan recall has revived a number of issues, including a ...
Breaking Medicine Technology: